Skip to main content
. 2013 Oct 4;14:210. doi: 10.1186/1471-2369-14-210

Table 3.

Linear regression for outcome eGFR at twelve months among those who did not reach the endpoint of ESRD by twelve months using focal as the reference group

 
eGFR at 12 months (n = 57)
  β p-value
eGFR at biopsy
0.35
<0.001
Age at biopsy (years)
-0.52
0.003
Crescentic class
-11.35
0.092
Mixed class
-21.25
0.001
Sclerotic class -23.67 0.006